chartexchange

Vaxart Inc (VXRT) (Q3 2026) Earnings Call Highlights: Cash Runway Into Q2 2027, COVID-19 ...

GuruFocus | Nov 7, 2026 12:17 AM EST

Vaxart Inc (VXRT) ended Q3 2026 with $65.5 million in cash while delaying its BARDA-funded Phase IIb COVID-19 data readout to mid-2027 and navigating a tougher norovirus partnering market. Related Stocks: VXRT ,

Read original article